SKI Market

A+| A| A-|

Indian Indices

Sensex

74,616.58 509.73
( 0.69%)

Global Indices

Nasdaq

46,689.37 163.69
(0.35%)

Dow Jones

6,632.05 28.36
(0.43%)

Hang Seng

53,529.44 115.76
(0.22%)

Nikkei 225

10,436.29 71.50
(0.69%)

Forex

USD-INR

92.68 -0.34
(-0.37%)

EUR-INR

106.73 -0.59
(-0.55%)

GBP-INR

122.22 -0.80
(-0.65%)

JPY-INR

0.58 0.00
(-0.50%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

16.5329749

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

232.81

51.96

EPS(TTM)

Face Value()

Div & Yield %

0.16

Back

Nestle India consolidated net profit declines 17.38% in the September 2025 quarter

Oct 16,2025

Net profit of Nestle India declined 17.38% to Rs 743.17 crore in the quarter ended September 2025 as against Rs 899.49 crore during the previous quarter ended September 2024. Sales rose 10.95% to Rs 5630.23 crore in the quarter ended September 2025 as against Rs 5074.76 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	5630.23	5074.76	11
OPM %	21.79	22.94	-
PBDT	1181.84	1138.65	4
PBT	1018.49	1017.05	0
NP	743.17	899.49	-17

74,616.58 509.73 ( 0.69%)

46,689.37 163.69 (0.35%)

6,632.05 28.36 (0.43%)

53,529.44 115.76 (0.22%)

10,436.29 71.50 (0.69%)

92.68 -0.34 (-0.37%)

106.73 -0.59 (-0.55%)

122.22 -0.80 (-0.65%)

0.58 0.00 (-0.50%)